Current Treatment Gaps for Myasthenia Gravis
Dr. Barnett-Tapia reviews the gaps that exist between available MG treatments and the related adverse effects profile and treatment goals, as well as what patients consider to be acceptable or less burdensome symptoms.
- - - -
Presented by the CME Institute of Physicians Postgraduate Press, Inc. and supported by an educational grant from argenx.
Complete the post-test for this activity at https://tinyurl.com/yt8y74au until 4/30/2023.
Vera Bril, MD, FRCPC: Division of Neurology, University of Toronto and University Health Network
Nicholas J. Silvestri, MD, FAAN: University at Buffalo Jacobs School of Medicine and Biosciences, New York
Carolina Barnett-Tapia, MD, PhD: Division of Neurology, University of Toronto and University Health Network